Nombre del producto:4-methyl-3-[(1r,3s)-1-(3-bromophenyl)-3-methylcyclobutyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione

IUPAC Name:4-methyl-3-[(1r,3s)-1-(3-bromophenyl)-3-methylcyclobutyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione

CAS:2573776-89-1
Fórmula molecular:C14H16BrN3S
Pureza:95%+
Número de catálogo:CM1075491
Peso molecular:338.27

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2573776-89-1
Fórmula molecular:C14H16BrN3S
Punto de fusión:-
Código de sonrisas:CN1C([C@]2(C[C@@H](C)C2)C3=CC(Br)=CC=C3)=NNC1=S
Densidad:
Número de catálogo:CM1075491
Peso molecular:338.27
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Column Infos

NX-1607
Nurix disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA. This is the first inhibitor of CBL-B to advance into clinical studies and a prime example of Nurix’s ability to target previously undruggable E3 ligases.

Related Products